ID   STK26_HUMAN             Reviewed;         416 AA.
AC   Q9P289; B2RAU2; Q3ZB77; Q8NC04; Q9BXC3; Q9BXC4;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2001, sequence version 2.
DT   15-MAR-2017, entry version 146.
DE   RecName: Full=Serine/threonine-protein kinase 26 {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:11641781};
DE   AltName: Full=MST3 and SOK1-related kinase {ECO:0000303|PubMed:11741893};
DE   AltName: Full=Mammalian STE20-like protein kinase 4 {ECO:0000303|PubMed:11641781};
DE            Short=MST-4 {ECO:0000305};
DE            Short=STE20-like kinase MST4 {ECO:0000305};
DE   AltName: Full=Serine/threonine-protein kinase MASK {ECO:0000305};
GN   Name=STK26 {ECO:0000312|HGNC:HGNC:18174};
GN   Synonyms=MASK {ECO:0000303|PubMed:11741893},
GN   MST4 {ECO:0000303|PubMed:11641781};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=11641781; DOI=10.1038/sj.onc.1204818;
RA   Lin J.-L., Chen H.-C., Fang H.-I., Robinson D., Kung H.-J.,
RA   Shih H.-M.;
RT   "MST4, a new Ste20-related kinase that mediates cell growth and
RT   transformation via modulating ERK pathway.";
RL   Oncogene 20:6559-6569(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Fetal brain;
RX   PubMed=11306563; DOI=10.1074/jbc.M009323200;
RA   Qian Z., Lin C., Espinosa R., LeBeau M., Rosner M.R.;
RT   "Cloning and characterization of MST4, a novel Ste20-like kinase.";
RL   J. Biol. Chem. 276:22439-22445(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=11741893; DOI=10.1074/jbc.M110882200;
RA   Dan I., Ong S.E., Watanabe N.M., Blagoev B., Nielsen M.M.,
RA   Kajikawa E., Kristiansen T.Z., Mann M., Pandey A.;
RT   "Cloning of MASK, a novel member of the mammalian germinal center
RT   kinase III subfamily, with apoptosis-inducing properties.";
RL   J. Biol. Chem. 277:5929-5939(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-178, INTERACTION WITH
RP   GOLGA2, AND ENZYME REGULATION.
RX   PubMed=15037601; DOI=10.1083/jcb.200310061;
RA   Preisinger C., Short B., De Corte V., Bruyneel E., Haas A.,
RA   Kopajtich R., Gettemans J., Barr F.A.;
RT   "YSK1 is activated by the Golgi matrix protein GM130 and plays a role
RT   in cell migration through its substrate 14-3-3zeta.";
RL   J. Cell Biol. 164:1009-1020(2004).
RN   [10]
RP   INTERACTION WITH PDCD10, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17360971; DOI=10.1091/mbc.E06-07-0608;
RA   Ma X., Zhao H., Shan J., Long F., Chen Y., Chen Y., Zhang Y., Han X.,
RA   Ma D.;
RT   "PDCD10 interacts with Ste20-related kinase MST4 to promote cell
RT   growth and transformation via modulation of the ERK pathway.";
RL   Mol. Biol. Cell 18:1965-1978(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4 AND THR-178, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-300; SER-304 AND
RP   SER-306, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   INTERACTION WITH PDCD10.
RX   PubMed=19370760; DOI=10.1002/humu.20996;
RA   Voss K., Stahl S., Hogan B.M., Reinders J., Schleider E.,
RA   Schulte-Merker S., Felbor U.;
RT   "Functional analyses of human and zebrafish 18-amino acid in-frame
RT   deletion pave the way for domain mapping of the cerebral cavernous
RT   malformation 3 protein.";
RL   Hum. Mutat. 30:1003-1011(2009).
RN   [14]
RP   INTERACTION WITH CTTNBP2NL.
RX   PubMed=18782753; DOI=10.1074/mcp.M800266-MCP200;
RA   Goudreault M., D'Ambrosio L.M., Kean M.J., Mullin M.J., Larsen B.G.,
RA   Sanchez A., Chaudhry S., Chen G.I., Sicheri F., Nesvizhskii A.I.,
RA   Aebersold R., Raught B., Gingras A.C.;
RT   "A PP2A phosphatase high density interaction network identifies a
RT   novel striatin-interacting phosphatase and kinase complex linked to
RT   the cerebral cavernous malformation 3 (CCM3) protein.";
RL   Mol. Cell. Proteomics 8:157-171(2009).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-4; THR-178 AND SER-300, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-178, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   INTERACTION WITH PDCD10 AND GOLGA2, AND SUBCELLULAR LOCATION.
RX   PubMed=20332113; DOI=10.1242/jcs.061341;
RA   Fidalgo M., Fraile M., Pires A., Force T., Pombo C., Zalvide J.;
RT   "CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and
RT   cell orientation.";
RL   J. Cell Sci. 123:1274-1284(2010).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-4, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-4; SER-300; SER-304 AND SER-306, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; THR-178; SER-325;
RP   THR-327 AND THR-328, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 1-300 IN COMPLEX WITH
RP   QUINAZOLIN INHIBITOR, AND SUBUNIT.
RX   PubMed=20730082; DOI=10.1371/journal.pone.0011905;
RA   Record C.J., Chaikuad A., Rellos P., Das S., Pike A.C., Fedorov O.,
RA   Marsden B.D., Knapp S., Lee W.H.;
RT   "Structural comparison of human mammalian ste20-like kinases.";
RL   PLoS ONE 5:E11905-E11905(2010).
RN   [25]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-9; TRP-36 AND CYS-45.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Mediator of cell growth. Modulates apoptosis.
CC       {ECO:0000269|PubMed:11641781, ECO:0000269|PubMed:17360971}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:11641781}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Interaction with Golgi matrix protein GOLGA2
CC       leads to autophosphorylation on Thr-178, possibly as a consequence
CC       of stabilization of dimer formation. May also be activated by C-
CC       terminal cleavage. {ECO:0000269|PubMed:15037601}.
CC   -!- SUBUNIT: Homodimer. Interacts with PDCD10 and GOLGA2. Interacts
CC       with CTTNBP2NL. {ECO:0000269|PubMed:15037601,
CC       ECO:0000269|PubMed:17360971, ECO:0000269|PubMed:18782753,
CC       ECO:0000269|PubMed:19370760, ECO:0000269|PubMed:20332113,
CC       ECO:0000269|PubMed:20730082}.
CC   -!- INTERACTION:
CC       Self; NbExp=4; IntAct=EBI-618239, EBI-618239;
CC       Q9Y376:CAB39; NbExp=6; IntAct=EBI-618239, EBI-306905;
CC       Q9P2B4:CTTNBP2NL; NbExp=4; IntAct=EBI-618239, EBI-1774273;
CC       Q9BUL8:PDCD10; NbExp=7; IntAct=EBI-618239, EBI-740195;
CC       Q5VSL9:STRIP1; NbExp=2; IntAct=EBI-618239, EBI-1773588;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Golgi apparatus membrane;
CC       Peripheral membrane protein; Cytoplasmic side. Note=Localizes to
CC       the Golgi apparatus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9P289-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P289-2; Sequence=VSP_041469;
CC       Name=3; Synonyms=MST4a;
CC         IsoId=Q9P289-3; Sequence=VSP_041470;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF231012; AAK38484.1; -; mRNA.
DR   EMBL; AF344882; AAK29620.1; -; mRNA.
DR   EMBL; AF344883; AAK29621.1; -; mRNA.
DR   EMBL; AB040057; BAA92785.2; -; mRNA.
DR   EMBL; BT020099; AAV38902.1; -; mRNA.
DR   EMBL; AK075107; BAC11406.1; -; mRNA.
DR   EMBL; AK314356; BAG36989.1; -; mRNA.
DR   EMBL; AL109749; CAI42079.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11786.1; -; Genomic_DNA.
DR   EMBL; CH471107; EAX11787.1; -; Genomic_DNA.
DR   EMBL; BC098315; AAH98315.1; -; mRNA.
DR   EMBL; BC103503; AAI03504.1; -; mRNA.
DR   CCDS; CCDS14631.1; -. [Q9P289-1]
DR   CCDS; CCDS43995.1; -. [Q9P289-3]
DR   CCDS; CCDS48168.1; -. [Q9P289-2]
DR   RefSeq; NP_001035917.1; NM_001042452.1. [Q9P289-3]
DR   RefSeq; NP_001035918.1; NM_001042453.1. [Q9P289-2]
DR   RefSeq; NP_057626.2; NM_016542.3. [Q9P289-1]
DR   UniGene; Hs.444247; -.
DR   PDB; 3GGF; X-ray; 2.35 A; A/B=1-300.
DR   PDB; 3W8I; X-ray; 2.40 A; B=346-416.
DR   PDB; 4FZA; X-ray; 3.15 A; B=18-297.
DR   PDB; 4FZD; X-ray; 3.25 A; B=18-297, C=323-327.
DR   PDB; 4FZF; X-ray; 3.64 A; B=18-297.
DR   PDB; 4GEH; X-ray; 1.95 A; B/D=325-413.
DR   PDBsum; 3GGF; -.
DR   PDBsum; 3W8I; -.
DR   PDBsum; 4FZA; -.
DR   PDBsum; 4FZD; -.
DR   PDBsum; 4FZF; -.
DR   PDBsum; 4GEH; -.
DR   ProteinModelPortal; Q9P289; -.
DR   SMR; Q9P289; -.
DR   BioGrid; 119722; 75.
DR   DIP; DIP-34049N; -.
DR   IntAct; Q9P289; 33.
DR   STRING; 9606.ENSP00000377867; -.
DR   BindingDB; Q9P289; -.
DR   ChEMBL; CHEMBL5941; -.
DR   GuidetoPHARMACOLOGY; 2287; -.
DR   iPTMnet; Q9P289; -.
DR   PhosphoSitePlus; Q9P289; -.
DR   SwissPalm; Q9P289; -.
DR   BioMuta; MST4; -.
DR   DMDM; 73621232; -.
DR   EPD; Q9P289; -.
DR   MaxQB; Q9P289; -.
DR   PaxDb; Q9P289; -.
DR   PeptideAtlas; Q9P289; -.
DR   PRIDE; Q9P289; -.
DR   DNASU; 51765; -.
DR   Ensembl; ENST00000394334; ENSP00000377867; ENSG00000134602. [Q9P289-1]
DR   Ensembl; ENST00000394335; ENSP00000377868; ENSG00000134602. [Q9P289-2]
DR   Ensembl; ENST00000496850; ENSP00000419702; ENSG00000134602. [Q9P289-3]
DR   GeneID; 51765; -.
DR   KEGG; hsa:51765; -.
DR   UCSC; uc004ewk.2; human. [Q9P289-1]
DR   CTD; 51765; -.
DR   DisGeNET; 51765; -.
DR   GeneCards; STK26; -.
DR   HGNC; HGNC:18174; STK26.
DR   HPA; HPA059921; -.
DR   MIM; 300547; gene.
DR   neXtProt; NX_Q9P289; -.
DR   OpenTargets; ENSG00000134602; -.
DR   eggNOG; KOG0201; Eukaryota.
DR   eggNOG; ENOG410XP9G; LUCA.
DR   GeneTree; ENSGT00810000125395; -.
DR   HOGENOM; HOG000234203; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; Q9P289; -.
DR   KO; K08838; -.
DR   PhylomeDB; Q9P289; -.
DR   Reactome; R-HSA-111465; Apoptotic cleavage of cellular proteins.
DR   SignaLink; Q9P289; -.
DR   SIGNOR; Q9P289; -.
DR   EvolutionaryTrace; Q9P289; -.
DR   GeneWiki; MST4; -.
DR   GenomeRNAi; 51765; -.
DR   PMAP-CutDB; Q9P289; -.
DR   PRO; PR:Q9P289; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000134602; -.
DR   ExpressionAtlas; Q9P289; baseline and differential.
DR   Genevisible; Q9P289; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0071944; C:cell periphery; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0097194; P:execution phase of apoptosis; TAS:Reactome.
DR   GO; GO:0030033; P:microvillus assembly; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0045595; P:regulation of cell differentiation; IBA:GO_Central.
DR   GO; GO:1903205; P:regulation of hydrogen peroxide-induced cell death; IMP:UniProtKB.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Apoptosis;
KW   ATP-binding; Complete proteome; Cytoplasm; Golgi apparatus; Kinase;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   CHAIN         2    416       Serine/threonine-protein kinase 26.
FT                                /FTId=PRO_0000086404.
FT   DOMAIN       24    274       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      30     38       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    144    144       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING      53     53       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     178    178       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:15037601}.
FT   MOD_RES     300    300       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     304    304       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     306    306       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     309    309       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99JT2}.
FT   MOD_RES     325    325       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     327    327       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     328    328       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      15     91       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041469.
FT   VAR_SEQ     200    261       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11306563}.
FT                                /FTId=VSP_041470.
FT   VARIANT       9      9       Q -> R (in dbSNP:rs56035648).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040844.
FT   VARIANT      36     36       G -> W (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040845.
FT   VARIANT      45     45       R -> C (in dbSNP:rs56044451).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040846.
FT   HELIX        20     23       {ECO:0000244|PDB:3GGF}.
FT   STRAND       24     32       {ECO:0000244|PDB:3GGF}.
FT   STRAND       34     43       {ECO:0000244|PDB:3GGF}.
FT   TURN         44     46       {ECO:0000244|PDB:3GGF}.
FT   STRAND       49     56       {ECO:0000244|PDB:3GGF}.
FT   TURN         58     60       {ECO:0000244|PDB:4FZD}.
FT   HELIX        63     74       {ECO:0000244|PDB:3GGF}.
FT   STRAND       85     91       {ECO:0000244|PDB:3GGF}.
FT   STRAND       94    100       {ECO:0000244|PDB:3GGF}.
FT   STRAND      104    106       {ECO:0000244|PDB:3GGF}.
FT   HELIX       107    111       {ECO:0000244|PDB:3GGF}.
FT   HELIX       118    132       {ECO:0000244|PDB:3GGF}.
FT   STRAND      138    142       {ECO:0000244|PDB:3GGF}.
FT   HELIX       147    149       {ECO:0000244|PDB:3GGF}.
FT   STRAND      150    152       {ECO:0000244|PDB:3GGF}.
FT   STRAND      158    161       {ECO:0000244|PDB:3GGF}.
FT   TURN        162    164       {ECO:0000244|PDB:4FZD}.
FT   TURN        172    174       {ECO:0000244|PDB:4FZA}.
FT   TURN        176    178       {ECO:0000244|PDB:4FZA}.
FT   HELIX       188    191       {ECO:0000244|PDB:3GGF}.
FT   HELIX       199    214       {ECO:0000244|PDB:3GGF}.
FT   TURN        218    221       {ECO:0000244|PDB:3GGF}.
FT   HELIX       224    233       {ECO:0000244|PDB:3GGF}.
FT   STRAND      241    243       {ECO:0000244|PDB:4FZA}.
FT   HELIX       245    254       {ECO:0000244|PDB:3GGF}.
FT   HELIX       259    261       {ECO:0000244|PDB:3GGF}.
FT   HELIX       265    269       {ECO:0000244|PDB:3GGF}.
FT   HELIX       272    277       {ECO:0000244|PDB:3GGF}.
FT   HELIX       281    284       {ECO:0000244|PDB:3GGF}.
FT   HELIX       285    296       {ECO:0000244|PDB:3GGF}.
FT   HELIX       346    350       {ECO:0000244|PDB:3W8I}.
FT   HELIX       352    355       {ECO:0000244|PDB:4GEH}.
FT   HELIX       357    366       {ECO:0000244|PDB:4GEH}.
FT   TURN        367    370       {ECO:0000244|PDB:3W8I}.
FT   HELIX       372    391       {ECO:0000244|PDB:4GEH}.
FT   HELIX       395    409       {ECO:0000244|PDB:4GEH}.
SQ   SEQUENCE   416 AA;  46529 MW;  3E31B7E3CBDA5768 CRC64;
     MAHSPVAVQV PGMQNNIADP EELFTKLERI GKGSFGEVFK GIDNRTQQVV AIKIIDLEEA
     EDEIEDIQQE ITVLSQCDSS YVTKYYGSYL KGSKLWIIME YLGGGSALDL LRAGPFDEFQ
     IATMLKEILK GLDYLHSEKK IHRDIKAANV LLSEQGDVKL ADFGVAGQLT DTQIKRNTFV
     GTPFWMAPEV IQQSAYDSKA DIWSLGITAI ELAKGEPPNS DMHPMRVLFL IPKNNPPTLV
     GDFTKSFKEF IDACLNKDPS FRPTAKELLK HKFIVKNSKK TSYLTELIDR FKRWKAEGHS
     DDESDSEGSD SESTSRENNT HPEWSFTTVR KKPDPKKVQN GAEQDLVQTL SCLSMIITPA
     FAELKQQDEN NASRNQAIEE LEKSIAVAEA ACPGITDKMV KKLIEKFQKC SADESP
//
